108 related articles for article (PubMed ID: 3559119)
1. Hypercalcemia of cancer in the digestive tract.
Monno S; Nagata A; Furuta S
J Clin Gastroenterol; 1987 Feb; 9(1):78-82. PubMed ID: 3559119
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia in head and neck carcinoma. Incidence and prognosis.
Won C; Decker DA; Drelichman A; Al-Sarraf M; Reed ML
Cancer; 1983 Dec; 52(12):2261-3. PubMed ID: 6640497
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
[TBL] [Abstract][Full Text] [Related]
5. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
Wimalawansa SJ
Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
[TBL] [Abstract][Full Text] [Related]
6. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
Robertson RP; Baylink DJ; Metz SA; Cummings KB
J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-related protein and hypercalcemia.
Rankin W; Grill V; Martin TJ
Cancer; 1997 Oct; 80(8 Suppl):1564-71. PubMed ID: 9362423
[TBL] [Abstract][Full Text] [Related]
9. [Hypercalcemia in breast cancer].
Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868
[TBL] [Abstract][Full Text] [Related]
10. Management and prognostic significance of hypercalcemia in renal cell carcinoma.
Chasan SA; Pothel LR; Huben RP
Urology; 1989 Mar; 33(3):167-70. PubMed ID: 2521966
[TBL] [Abstract][Full Text] [Related]
11. Treatment of malignancy-associated hypercalcemia with YM175, a new bisphosphonate: elevated threshold for parathyroid hormone secretion in hypercalcemic patients.
Fukumoto S; Matsumoto T; Takebe K; Onaya T; Eto S; Nawata H; Ogata E
J Clin Endocrinol Metab; 1994 Jul; 79(1):165-70. PubMed ID: 8027221
[TBL] [Abstract][Full Text] [Related]
12. Plasma PTH and PTH-rP levels and clodronate therapy in cancer patients with hypercalcemia.
Su RJ; Chang CC; Tsai KS
J Formos Med Assoc; 1993 Nov; 92(11):977-82. PubMed ID: 7910069
[TBL] [Abstract][Full Text] [Related]
13. Elevated prostaglandin and indomethacin-responsive hypercalcemia in a patient with malignant pheochromocytoma.
Uchida T; Kuwao S; Ishibashi A; Koshiba K
J Urol; 1985 Oct; 134(4):712-3. PubMed ID: 4032577
[No Abstract] [Full Text] [Related]
14. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.
Hiraki A; Ueoka H; Bessho A; Segawa Y; Takigawa N; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
Cancer; 2002 Oct; 95(8):1706-13. PubMed ID: 12365018
[TBL] [Abstract][Full Text] [Related]
16. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
Shaw JW; Oldham SB; Rosoff L; Bethune JE; Fichman MP
J Clin Invest; 1977 Jan; 59(1):14-21. PubMed ID: 187621
[TBL] [Abstract][Full Text] [Related]
17. [Hypercalcemia and squamous cell carcinoma of the upper respiratory-digestive tracts. Incidence and prognosis].
Degardin M; Nguyen M; Beaurin D; Lesoin A; Fournier C; Lefebvre JL; Cappelaere P
Bull Cancer; 1995 Nov; 82(11):975-80. PubMed ID: 8535025
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
20. Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemia.
Body JJ; Dumon JC; Seraj F; Cleeren A
J Clin Endocrinol Metab; 1992 Jun; 74(6):1385-8. PubMed ID: 1592885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
